CIK: 0001687078
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CGEM | Cullinan Therapeutics INC | Stock-Other | 9.06% | -0.67% | — | |
| 2 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 6.45% | -6.45% | EXIT | |
| 3 | LQDA | Liquidia CORP | Stock-Other | 5.53% | -1.43% | +600.43% | |
| 4 | TRVI | Trevi Therapeutics INC | Stock-Other | 4.71% | -1.67% | -3.52% | |
| 5 | EWTX | Edgewise Therapeutics INC | Stock-Other | 4.70% | -0.66% | -3.81% | |
| 6 | RVMD | Revolution Medicines INC | Stock-Healthcare | 4.61% | -0.80% | +60.16% | |
| 7 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 4.06% | -0.65% | — | |
| 8 | QURE | uniQure N.V. | Stock-Other | 3.78% | -2.05% | — | |
| 9 | PTCT | Ptc Therapeutics INC | Stock-Healthcare | 3.74% | -3.74% | EXIT | |
| 10 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 3.22% | -0.80% | -2.76% | |
| 11 | DYN | Dyne Therapeutics INC | Stock-Other | 3.15% | -1.18% | -2.83% | |
| 12 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 3.08% | -1.29% | -3.70% | |
| 13 | STOK | Stoke Therapeutics INC | Stock-Other | 2.80% | -0.87% | -2.46% | |
| 14 | ALMS | Alumis INC | Stock-Other | 2.68% | +1.38% | — | |
| 15 | URGN | UroGen Pharma Ltd. | Stock-Other | 2.52% | -1.21% | +597.32% | |
| 16 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 2.49% | +0.15% | -3.53% | |
| 17 | PVLA | Palvella Therapeutics INC | Stock-Other | 2.46% | -0.47% | +205.16% | |
| 18 | NTRA | Natera INC | Stock-Healthcare | 2.45% | -1.01% | -5.43% | |
| 19 | CRVS | Corvus Pharmaceuticals INC | Stock-Other | 2.42% | -0.53% | — | |
| 20 | DBVT | Dbv Technologies Sa-spon Adr | Stock-Other | 2.19% | +6.22% | -5.47% | |
| 21 | RLAY | Relay Therapeutics INC | Stock-Other | 2.16% | -0.35% | -2.20% | |
| 22 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 2.11% | -0.61% | — | |
| 23 | DRUG | Bright Minds Biosciences INC | Stock-Other | 2.06% | -0.86% | — | |
| 24 | PTGX | Protagonist Therapeutics INC | Stock-Other | 1.99% | -1.99% | EXIT | |
| 25 | ✓ | Engene Holdings INC | Stock-Other | 1.90% | -0.93% | +247.14% | |
| 26 | CNTX | Context Therapeutics INC | Stock-Other | 1.80% | +0.36% | -27.38% | |
| 27 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 1.77% | -0.43% | — | |
| 28 | VTYXUSD | Ventyx Biosciences INC | Stock-Other | 1.69% | -1.69% | EXIT | |
| 29 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 1.68% | +0.09% | +4.01% | |
| 30 | BLTE | Belite Bio INC - Adr | Stock-Other | 1.61% | -0.53% | — | |
| 31 | RAPT | Rapt Therapeutics INC | Stock-Other | 1.54% | -1.54% | EXIT | |
| 32 | CLYM | Climb Bio INC | Stock-Other | 1.22% | +0.15% | — | |
| 33 | ABVX | Abivax Sa-adr | Stock-Other | 0.87% | +0.05% | — | |
| 34 | RCKT | Rocket Pharmaceuticals INC | Stock-Other | 0.64% | -0.64% | EXIT | |
| 35 | MAZE | Maze Therapeutics INC | Stock-Other | 0.38% | -0.38% | EXIT | |
| 36 | EVMN | Evommune INC | Stock-Other | 0.22% | +2.36% | — | |
| 37 | SRPT | Sarepta Therapeutics INC | Stock-Healthcare | 0.17% | -0.17% | EXIT | |
| 38 | HOWL | Werewolf Therapeutics INC | Stock-Other | 0.10% | -0.02% | -42.15% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LQDA | Liquidia CORP | +4.8% | +600.43% | Add |
| 2 | RVMD | Revolution Medicines INC | +2.2% | +60.16% | Add |
| 3 | URGN | UroGen Pharma Ltd. | +2.1% | +597.32% | Add |
| 4 | PVLA | Palvella Therapeutics INC | +1.8% | +205.16% | Add |
| 5 | CGEM | Cullinan Therapeutics INC | +1.6% | — | Unchanged |
| 6 | ✓ | Engene Holdings INC | +1.3% | +247.14% | Add |
| 7 | DBVT | Dbv Technologies Sa-spon Adr | +0.5% | -5.47% | Trim |
| 8 | RLAY | Relay Therapeutics INC | +0.2% | -2.20% | Trim |
| 9 | DYN | Dyne Therapeutics INC | +0.2% | -2.83% | Trim |
| 10 | EWTX | Edgewise Therapeutics INC | +0.1% | -3.81% | Trim |
| 11 | NTRA | Natera INC | -0.2% | -5.43% | Trim |
| 12 | SNDX | Syndax Pharmaceuticals INC | -0.2% | -2.76% | Trim |
| 13 | TARS | Tarsus Pharmaceuticals INC | -0.2% | -3.70% | Trim |
| 14 | STOK | Stoke Therapeutics INC | -0.2% | -2.46% | Trim |
| 15 | TRVI | Trevi Therapeutics INC | -0.4% | -3.52% | Trim |
| 16 | PTCT | Ptc Therapeutics INC | -0.7% | -1.93% | Trim |
| 17 | HOWL | Werewolf Therapeutics INC | -0.7% | -42.15% | Trim |
| 18 | MDGL | Madrigal Pharmaceuticals INC | -1.1% | -3.62% | Trim |
| 19 | RCKT | Rocket Pharmaceuticals INC | -1.4% | -59.37% | Trim |
| 20 | ORIC | Oric Pharmaceuticals INC | -1.7% | +4.01% | Add |
| 21 | SRPT | Sarepta Therapeutics INC | -2% | -90.00% | Trim |
| 22 | AGIO | Agios Pharmaceuticals INC | — | NEW | New buy |
| 23 | RNAGBP | Avidity Biosciences INC | — | EXIT | Sold out |
| 24 | QURE | uniQure N.V. | — | NEW | New buy |
| 25 | ZLAB | Zai Lab Ltd-adr | — | EXIT | Sold out |
| 26 | ALMS | Alumis INC | — | NEW | New buy |
| 27 | CRVS | Corvus Pharmaceuticals INC | — | NEW | New buy |
| 28 | GLUE | Monte Rosa Therapeutics INC | — | NEW | New buy |
| 29 | DRUG | Bright Minds Biosciences INC | — | NEW | New buy |
| 30 | CMPX | Compass Therapeutics INC | — | EXIT | Sold out |
| 31 | PTGX | Protagonist Therapeutics INC | — | NEW | New buy |
| 32 | ALKS | Alkermes plc | — | EXIT | Sold out |
| 33 | VERA | Vera Therapeutics INC | — | EXIT | Sold out |
| 34 | ARQT | Arcutis Biotherapeutics INC | — | NEW | New buy |
| 35 | JANX | Janux Therapeutics INC | — | EXIT | Sold out |
| 36 | VTYXUSD | Ventyx Biosciences INC | — | NEW | New buy |
| 37 | BLTE | Belite Bio INC - Adr | — | NEW | New buy |
| 38 | RAPT | Rapt Therapeutics INC | — | NEW | New buy |
| 39 | SPRY | Ars Pharmaceuticals INC | — | EXIT | Sold out |
| 40 | RARE | Ultragenyx Pharmaceutical In | — | EXIT | Sold out |
| 41 | WVE | Wave Life Sciences Ltd. | — | EXIT | Sold out |
| 42 | CLYM | Climb Bio INC | — | NEW | New buy |
| 43 | SLNOEUR | Soleno Therapeutics INC | — | EXIT | Sold out |
| 44 | SLDB | Solid Biosciences INC | — | EXIT | Sold out |
| 45 | AKBA | Akebia Therapeutics INC | — | EXIT | Sold out |
| 46 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 47 | DSGN | Design Therapeutics INC | — | EXIT | Sold out |
| 48 | RNAC | Cartesian Therapeutics INC | — | EXIT | Sold out |
| 49 | MAZE | Maze Therapeutics INC | — | NEW | New buy |
| 50 | RAPP | Rapport Therapeutics INC | — | EXIT | Sold out |